132 related articles for article (PubMed ID: 16908425)
1. Micronization and polymorphic conversion of tolbutamide and barbital by rapid expansion of supercritical solutions.
Shinozaki H; Oguchi T; Suzuki S; Aoki K; Sako T; Morishita S; Tozuka Y; Moribe K; Yamamoto K
Drug Dev Ind Pharm; 2006 Aug; 32(7):877-91. PubMed ID: 16908425
[TBL] [Abstract][Full Text] [Related]
2. Micronization of dihydroartemisinin by rapid expansion of supercritical solutions.
Chingunpitak J; Puttipipatkhachorn S; Tozuka Y; Moribe K; Yamamoto K
Drug Dev Ind Pharm; 2008 Jun; 34(6):609-17. PubMed ID: 18568911
[TBL] [Abstract][Full Text] [Related]
3. Micronization of phenylbutazone by rapid expansion of supercritical CO2 solution.
Moribe K; Tsutsumi S; Morishita S; Shinozaki H; Tozuka Y; Oguchi T; Yamamoto K
Chem Pharm Bull (Tokyo); 2005 Aug; 53(8):1025-8. PubMed ID: 16079541
[TBL] [Abstract][Full Text] [Related]
4. Crystal doping aided by rapid expansion of supercritical solutions.
Vemavarapu C; Mollan MJ; Needham TE
AAPS PharmSciTech; 2002; 3(4):E29. PubMed ID: 12916923
[TBL] [Abstract][Full Text] [Related]
5. Micronization of magnolia bark extract with enhanced dissolution behavior by rapid expansion of supercritical solution.
He S; Zhang Z; Xu F; Zhang S; Lei Z
Chem Pharm Bull (Tokyo); 2010 Feb; 58(2):154-9. PubMed ID: 20118572
[TBL] [Abstract][Full Text] [Related]
6. [Micronization of magnolia bark extract by RESS as well as dissolution and pharmacokinetics evaluation].
He S; Lei ZJ; Zhang SY; Zhang ZY
Yao Xue Xue Bao; 2009 May; 44(5):532-9. PubMed ID: 19618732
[TBL] [Abstract][Full Text] [Related]
7. Micronization and microencapsulation of felodipine by supercritical carbon dioxide.
Chiou AH; Cheng HC; Wang DP
J Microencapsul; 2006 May; 23(3):265-76. PubMed ID: 16801239
[TBL] [Abstract][Full Text] [Related]
8. Formation of phenytoin nanoparticles using rapid expansion of supercritical solution with solid cosolvent (RESS-SC) process.
Thakur R; Gupta RB
Int J Pharm; 2006 Feb; 308(1-2):190-9. PubMed ID: 16352406
[TBL] [Abstract][Full Text] [Related]
9. Polymorphic properties of micronized carbamazepine produced by RESS.
Gosselin PM; Thibert R; Preda M; McMullen JN
Int J Pharm; 2003 Feb; 252(1-2):225-33. PubMed ID: 12550798
[TBL] [Abstract][Full Text] [Related]
10. A critical review on the particle generation and other applications of rapid expansion of supercritical solution.
Kumar R; Thakur AK; Banerjee N; Chaudhari P
Int J Pharm; 2021 Oct; 608():121089. PubMed ID: 34530097
[TBL] [Abstract][Full Text] [Related]
11. Nanoparticles in the pharmaceutical industry and the use of supercritical fluid technologies for nanoparticle production.
Sheth P; Sandhu H; Singhal D; Malick W; Shah N; Kislalioglu MS
Curr Drug Deliv; 2012 May; 9(3):269-84. PubMed ID: 22283656
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the Potential Use of Laminar Extrudates on Stabilizing Micronized Coumarin Particles by Supercritical Fluids (RESS)-Study of Different RESS Processing Variables and Mode of Operation.
Oliveira GE; Pinto JF
AAPS PharmSciTech; 2017 Oct; 18(7):2792-2807. PubMed ID: 28382603
[TBL] [Abstract][Full Text] [Related]
13. [Preparation of nanopaticles of SCF-CO2 extraction of Magnolia officinalis].
He S; Zhang S; Lei Z; Zhang Z
Zhongguo Zhong Yao Za Zhi; 2009 Feb; 34(4):390-3. PubMed ID: 19459296
[TBL] [Abstract][Full Text] [Related]
14. Supercritical fluid assisted atomization introduced by an enhanced mixer for micronization of lysozyme: Particle morphology, size and protein stability.
Du Z; Guan YX; Yao SJ; Zhu ZQ
Int J Pharm; 2011 Dec; 421(2):258-68. PubMed ID: 22001535
[TBL] [Abstract][Full Text] [Related]
15. Preparation and characterization of micronized artemisinin via a Rapid Expansion of Supercritical Solutions (RESS) Method.
Yu H; Zhao X; Zu Y; Zhang X; Zu B; Zhang X
Int J Mol Sci; 2012; 13(4):5060-5073. PubMed ID: 22606030
[TBL] [Abstract][Full Text] [Related]
16. Characterization of tolbutamide polymorphs (Burger's forms II and IV) and polymorphic transition behavior.
Kimura K; Hirayama F; Uekama K
J Pharm Sci; 1999 Apr; 88(4):385-91. PubMed ID: 10187747
[TBL] [Abstract][Full Text] [Related]
17. Reevaluation of solubility of tolbutamide and polymorphic transformation from Form I to unknown crystal form.
Hasegawa G; Komasaka T; Bando R; Yoshihashi Y; Yonemochi E; Fujii K; Uekusa H; Terada K
Int J Pharm; 2009 Mar; 369(1-2):12-8. PubMed ID: 19026732
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of wettability and dissolution properties of cilostazol using the supercritical antisolvent process: effect of various additives.
Kim MS; Kim JS; Hwang SJ
Chem Pharm Bull (Tokyo); 2010 Feb; 58(2):230-3. PubMed ID: 20118585
[TBL] [Abstract][Full Text] [Related]
19. Formation of ultrafine deferasirox particles via rapid expansion of supercritical solution (RESS process) using Taguchi approach.
Asghari I; Esmaeilzadeh F
Int J Pharm; 2012 Aug; 433(1-2):149-56. PubMed ID: 22583849
[TBL] [Abstract][Full Text] [Related]
20. Crystal polymorphs of barbital: news about a classic polymorphic system.
Zencirci N; Griesser UJ; Gelbrich T; Apperley DC; Harris RK
Mol Pharm; 2014 Jan; 11(1):338-50. PubMed ID: 24283960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
